Future Science Group
Browse
fon-2019-0141 Infographic.pdf (1.15 MB)
Download file

Infographic – Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design

Download (1.15 MB)
figure
posted on 2022-06-29, 08:47 authored by Figshare Future Science GroupFigshare Future Science Group, Daniel VT Catenacci, Anteneh Tesfaye, Mohamed Tejani, Eric Cheung, Peter Eisenberg, Aaron J Scott, Clarence Eng, James Hnatyszyn, Neyssa Marina, Janine Powers, Zev Wainberg

 Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design 

History

Usage metrics

    Future Oncology

    Categories

    Keywords

    FGFR2 amplification bemarituzumabgastric and esophageal adenocarcinomaPhase III study design

    Licence

    CC BY-NC-ND 4.0

    Exports